| Name | Title | Contact Details |
|---|
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
Med Channel is a Milton Village, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BSI was founded by Judith C. McDowall in 1985 to prepare documentation for FDA regulatory submissions. BSI began preparing peer reviewed technical reports for the National Toxicology Program in 1989. We obtained and have retained this prestigious
Ameri-Pac, Inc. is a manufacturer of animal health and nutrition specialty products for the pet food, companion animal, farm animal, veterinary and aquaculture industries. We are a family-owned business with three generations involved in the day-to-day
Medical Media Communications is a Des Plaines, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.